A SINGLE CENTER, RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF EBI-005 TOPICAL OPHTHALMIC SOLUTION FOR THE TREATMENT OF CHRONIC ALLERGIC CONJUNCTIVITIS USING AN ENVIRONMENTAL EXPOSURE CHAMBER

Registry ID
EBI-005-AC-1
Source registry
HEALTH_CANADA
Status
Ongoing
Study type
INTERVENTIONAL
Sponsor
ELEVEN BIOTHERAPEUTICS INC
Start date
2014-02-12
Last update
2014-01-29

Conditions

Related clinical trials

View on source registry